Cordlife Group (SGX:P8A), a cord blood banking company, has been directed by the Ministry of Health (MOH) to comply with new operational restrictions starting Sept. 15, according to a Friday filing on the Singapore Exchange.
Under the Third Notice issued by the MOH, the company must limit its cord blood collection, testing, processing, and storage to 30 units per month until Jan. 13, 2025.
The company has confirmed it will adhere to these restrictions, which will impact its operations and are expected to negatively affect its financial performance for the fiscal year ending Dec. 31, 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.